ThyssenKrupp Closes Terre Haute Steering Plant as Indiana Manufacturing Splits Between Legacy and Technology-Forward Facilities

ThyssenKrupp Presta North America filed a WARN Act notice June 30, eliminating 207 jobs at its Vigo County facility with a phased shutdown running August 2026 through March 2027, and the ThyssenKrupp Terre Haute plant closure is a technology story, not a cost story. The same 24-hour window brought a $103 million medical CDMO acquisition that gives Kimball Electronics' Indianapolis facility a concrete technology pipeline, and a €44 million headquarters inauguration by Endress+Hauser in Greenwood that pushes total Indiana campus investment past $71 million. Three announcements, three directions, here's what each one means for your operation.

Questions for Your Morning Huddle

Q: Why is ThyssenKrupp closing its Terre Haute, Indiana plant?
A: ThyssenKrupp filed a WARN Act notice June 30 citing changing customer requirements, volume developments, and cost structures, but the closing reflects a technology consolidation decision. ThyssenKrupp is actively investing in steer-by-wire and electromechanical brake systems while the Terre Haute plant produces conventional cold-forged steering components, exactly the category OEMs are phasing down. Production moves to the Hamilton, Ohio facility, which is receiving targeted investment, not just displaced volume.

Q: What does the ThyssenKrupp Terre Haute closure mean for Indiana auto suppliers?
A: If your facility supplies conventional mechanical subcomponents to automotive OEMs, the Terre Haute closure is a direct stress test for your own order book. OEM platform transitions toward electromechanical systems are already compressing demand for conventional components through 2027 and beyond, audit which programs you're on and where those programs sit in each OEM's platform roadmap before the next contract cycle.

Q: What is Kimball Electronics' acquisition of Helvoet and why does it matter for Indiana manufacturers?
A: Kimball Electronics acquired Helvoet Polymer Technologies, a European medical CDMO specializing in micro-molding for diagnostics and drug delivery, for $103 million. The acquisition gives Kimball's Indianapolis Post Road facility a concrete technology pipeline and cross-sell platform. The company rebrands to Kimball Solutions on July 1. If you're in the Indiana medical supply chain, this acquisition activates Kimball's Indianapolis operation, worth assessing whether you're a target for their outreach or a competitor to their newly acquired capability.

Today's three stories trace the same underlying split. Capital is moving away from conventional mechanical components and toward specialized, technology-forward manufacturing platforms, and Indiana is seeing both sides of that shift in the same 24-hour window. Understanding where your product portfolio, supply chain, and vendor relationships sit relative to that transition is a concrete action item.